The QualityStocks Daily Wednesday, February 1st, 2023

Today's Top 3 Investment Newsletters

InsiderTrades(MSGM) $21.4000 +713.69%

PennyStockScholar(HILS) $1.2000 +78.84%

OTCtipReporter(CNTX) $1.0600 +55.20%

The QualityStocks Daily Stock List

Cemtrex (CETX)

TaglichBrothers, StockMarketWatch, TraderPower, Broad Street, BUYINS.NET, InvestorPlace, OTCBB Journal, QualityStocks, MarketBeat, StocksImpossible, The Bowser Report, Jason Bond, Small Cap Firm, StockOodles, The Street, Stock Commander, AwesomeStocks, PennyStockProphet, Penny Pick Finders, OTCtipReporter, Profitable Trader Authority, Market FN, MarketClub Analysis, StockOnion, PennyStockScholar, Buzz Stocks, HotOTC, Penny Stock General, Investing Futures, Shiznit Stocks, StockHideout, Today's Stock Tip, The Best Newsletters, StockRunway, OTC Markets Group, Wall Street Resources, TopPennyStockMovers, StockRockandRoll, StockPicksNYC, Weekly Wizards, Penny Stock 101, PennyStockAlertsNYC, PennyStockLocks, SeeThruEquity Research, Schaeffer's and reported earlier on Cemtrex (CETX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cemtrex Inc. (NASDAQ: CETX) is a technology firm that is engaged in the provision of intelligent security systems, industrial solutions, advanced electronic systems, augmented and virtual reality and smart technology solutions.

The firm has its headquarters in Brooklyn, New York and was incorporated in 1998, on April 27th. Prior to its name change in December 2004, the firm was known as Diversified American Holding Inc. It operates as part of the industrial products industry, in the industrials sector, under the machinery sub-industry and has 19 companies in its corporate family.

The company operates through the industrial services and the advanced technologies segments. The former segment provides single-source expertise and services for plant maintenance, millwrighting, rigging and equipment disassembly, relocation and erection to its consumers. In addition to this, it also installs high precision equipment in different industrial markets which include printing and graphics, automotive, chemicals, packaging and industrial automation. On the other hand, the advanced technologies segment is involved in the delivery of technologies in the smart devices, wearables and IoT, as well as solutions for augmented and virtual reality, web and mobile, television and wearables. Its subsidiary Vicon Industries offers end-to-end security solutions that address government, industrial and corporate security challenges.

The enterprise’s Smart Desk product is the most advanced workstation in the world. Additionally, it also provides analytics-based recognition systems and browser-based monitoring systems for surveillance and security in commercial and industrial facilities, state and federal government offices, schools, universities, hospitals and federal prisons.

The company recently received a $1 million order to install a security technology system at a big corrections facility in the U.K. This contract reaffirms the positive demand for its security technology vertical and will encourage more facilities to choose the company’s technology, which will drive up sales and in turn, boost revenues.

Cemtrex (CETX), closed Wednesday's trading session at $11.8, up 68.331%, on 1,289,317 volume. The average volume for the last 3 months is 5.744M and the stock's 52-week low/high is $3.15/$27.30.

Kubient Inc. (KBNT)

StockRockandRoll, PennyStockLocks, Penny Stock 101, The Stock Dork, StreetInsider, Trades Of The Day, StockWireNews, StockStreetWire, Small Cap Firm, QualityStocks, MarketBeat and Fierce Analyst reported earlier on Kubient Inc. (KBNT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kubient, Inc. (NASDAQ: KBNT) is a technology firm that is focused on the development of a cloud-based software platform for the digital advertising industry.

The firm has its headquarters in New York and was incorporated in May 2017 by Paul Roberts. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe, with a focus on consumers in Russia and United States.

The company’s objective is to transform the digital advertising industry to marketing that’s audience based. Its next generation cloud-based infrastructure allows for efficient marketplace liquidity for sellers and buyers of digital advertising.

The enterprise’s products include a platform for real-time trading of digital, programmatic advertising known as the Audience Cloud. This independent platform is an open and flexible marketplace which facilitates automated transaction execution and intelligent-decision making, enabling publishers and advertisers to connect with, reach and monetize their audiences. It also allows sellers and buyers to transact with confidence in a fraud-free, honest and open environment. This solution also demands transparency and is available in any channel, including digital out-of-home, mobile, desktop and connected devices, as well as in any format whether audio, display, video and native.

The firm is focused on its growth strategy and vetting multiple acquisition targets on the mergers and acquisitions front in an effort to find companies which can add accretive value to it. This will help create shareholder value and encourage more investments into the firm, which will positively influence its growth.

Kubient Inc. (KBNT), closed Wednesday's trading session at $1.3, up 58.1701%, on 5,744,445 volume. The average volume for the last 3 months is 141.122M and the stock's 52-week low/high is $0.513/$2.425.

Bright Green Corp (BGXX)

QualityStocks and The Stock Dork reported earlier on Bright Green Corp (BGXX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bright Green Corp. (NASDAQ: BGXX) is a cannabis firm that is focused on growing, manufacturing and selling marijuana and marijuana-related products legally under state and federal laws for export, research and pharmaceutical applications.

The firm has its headquarters in Fort Lauderdale, Florida and was incorporated in 2019, on April 16th by Lynn Stockwell. It operates as part of the drug manufacturers-specialty and generic industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on the U.S.

The company is leveraging automation and technologically-driven research and development to grow pharmaceutical grade plants, including medical marijuana and marijuana. Its objective is to deliver consistent quality in an environmentally controlled, state-of-the-art, organic ecosystem.

The enterprise is planning to sell extracted oils from medicinal plants grown in these high-tech facilities and processed on-site via a proprietary system which vertically integrates the genetically altered growth of the plants to conform to automated growing systems. It is also focused on the development of marijuana strains and sales of products with high contents of cannabigerol (CBG) and cannabinol (CBN). The enterprise is engaged in cannabis cultivation, propagation and manufacturing of cannabis products including cannabis pre-rolls, flower, vape pens, concentrates, tinctures, capsules, topicals and any other marijuana-related products requested for authorized sales.

The company, which recently listed on the Nasdaq, is making significant progress in its development efforts to grow, manufacture and market federally-compliant medicinal cannabis. This will positively influence investments and revenues into the company and bolster its growth significantly.

Bright Green Corp (BGXX), closed Wednesday's trading session at $1.42, up 171.7703%, on 141,904,374 volume. The average volume for the last 3 months is 48.166M and the stock's 52-week low/high is $0.35/$58.00.

Golden Sun Education Group (GSUN)

We reported earlier on Golden Sun Education Group (GSUN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Golden Sun Education Group Ltd (NASDAQ: GSUN) is a holding firm that is principally engaged in the provision of educational services.

The firm has its headquarters in Shanghai, China and was incorporated in 1997. It operates as part of the education and training services industry, under the consumer defensive sector. The firm serves consumers in the People’s Republic of China.

The company mainly operates through the Primary and Secondary Schools Services; Tutorial; and Other Services segments. It has more than two decades of experience in offering educational services that focus on the development of each of its student’s potential and strengths, and the promotion of lifelong skills and interests in learning. The company primarily offers its services through operating subsidiaries.

The enterprise mainly provides professional financial education and training services. Its professional financial education services cover a range of categories including finance, tax and accounting, among others, in forms of online and in-person classes. This helps enterprises to improve the quality of financial operation and enables students to pass their professional certification examinations. It also provides middle and elementary schooling services; non-English foreign languages tutorial services; and logistics and consulting services. The logistics and consulting business primarily provides catering services to affiliated schools.

The firm, which recently announced its latest financial results, remains focused on expanding its business and market share, growing its business and achieving long-term development goals. This will improve brand awareness, expand its customer base and help create significant value for its shareholders.

Golden Sun Education Group (GSUN), closed Wednesday's trading session at $3.43, up 125.6579%, on 48,166,130 volume. The average volume for the last 3 months is 452,129 and the stock's 52-week low/high is $0.94/$95.00.

MicroAlgo (MLGO)

The Stock Dork, QualityStocks and Money Wealth Matters reported earlier on MicroAlgo (MLGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MicroAlgo Inc. (NASDAQ: MLGO) is an information technology firm that is focused on the development and delivery of central processing algorithm solutions to consumers in internet advertisement, gaming and intelligent chip industries.

The firm has its headquarters in Shenzhen, China. Prior to its name change, the firm was a holding company known as Venus Acquisition Corp. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in the People’s Republic of China.

The company operates through two segments, Central Processing Algorithm Services, and Intelligent Chips and Services. It provides comprehensive solutions to customers by integrating central processing algorithms with software or hardware, or both, thereby helping them to increase the number of customers, improve end-user satisfaction, achieve direct cost savings, reduce power consumption, and achieve technical goals. The company operates as a subsidiary of WiMi Hologram Cloud Inc.

The enterprise’s service offerings include algorithm optimization, accelerating computing power without the need for hardware upgrades, data processing, and data intelligence services. It also engages in the resale of intelligent chips and accessories; and provision of software development.

The firm, which recently appointed its first brand ambassador to help create an intersection between art and hospitality that offers its guests memorable experiences, is focused on elevating its industry profile and expanding its portfolio. This will help extend its consumer reach and open the firm up to new growth and investment opportunities.

MicroAlgo (MLGO), closed Wednesday's trading session at $2.08, off by 2.3474%, on 458,586 volume. The average volume for the last 3 months is 11,781 and the stock's 52-week low/high is $1.12/$71.50.

Natural Health Trends (NHTC)

The Online Investor, Wall Street Resources, StreetAuthority Daily, ProfitableTrading, TopStockAnalysts, Kiplinger Today, QualityStocks, MarketBeat, InvestorPlace, Barchart, One Hot Stock, Dividend Opportunities, Wall Street Daily, Hit and Run Candle Sticks, InvestorsUnderground, Daily Trade Alert, Cabot Wealth,, BUYINS.NET, Money Morning, Schaeffer's, Zacks, Shah's Insights & Indictments, Short Term Wealth, SmallCapVoice, StockMarketWatch, StrategicTechInvestor, The Street, VectorVest, Wealth Blueprint Letter and Rick Saddler reported earlier on Natural Health Trends (NHTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Natural Health Trends Corp. (NASDAQ: NHTC) (FRA: NAH) is a direct selling and e-commerce firm engaged in the provision of personal care, wellness and lifestyle products.

The firm has its headquarters in TsimShaTsui, Hong Kong and was incorporated in 1988. Prior to its name change in June 1993, the firm was known as Florida Institute of Massage Therapy Inc. It operates as part of the internet retail industry, under the consumer cyclical sector. The firm serves consumers across the globe, with a focus on those in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe.

The company markets premium quality personal care, wellness, and "quality of life" products under the NHT Global brand. It operates subsidiaries throughout Asia, the Americas, and Europe. The company generates most of its revenue from Hong Kong.

The enterprise provides wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also offers beauty products, such as age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the enterprise provides home appliances; daily products, such as oral care, hair care, and body care; and home appliances products. It sells its products directly to consumers, as well as through an e-commerce retail platform.

The company, which recently announced its latest financial results, remains focused on enhancing productivity, driving its growth and generating value for its shareholders.

Natural Health Trends (NHTC), closed Wednesday's trading session at $4.69, up 0.428266%, on 11,782 volume. The average volume for the last 3 months is 7,770 and the stock's 52-week low/high is $3.27/$8.00.

LuxUrban Hotels (LUXH)

We reported earlier on LuxUrban Hotels (LUXH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LuxUrban Hotels Inc. (NASDAQ: LUXH) is a short-term apartment rental operator focused on acquiring and managing a portfolio of short-term rental properties in metropolitan cities in the U.S.

The firm has its headquarters in Miami, Florida and was incorporated in 2017. Prior to its name change, the firm was known as CorpHousing LLC. It operates as part of the lodging industry, under the consumer cyclical sector. The firm serves consumers in the United States.

The company utilizes a long-term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in major metropolitan cities. Its future growth focuses primarily on seeking to create “win-win” opportunities for owners of dislocated hotels, including those impacted by COVID-19 travel restrictions, while providing favorable operating margins.

The enterprise operates its properties by leveraging technology to identify, acquire, manage, and market them globally to business and vacation travelers through various third-party sales and distribution channels, and the company's own online portal. Guests at its properties are provided the service under the company's consumer brand, LuxUrban. As of June 2022, it managed a portfolio of 584 multi-family and hotel units located in metropolitan cities in New York, California, Florida, Colorado,Massachusetts and Washington D.C.

The firm, which recently entered into a definitive agreement for the issuance and sale of its private placement units, remains dedicated to the development and application of bespoke central processing algorithms and the efficient delivery of services to its consumers. This will, in turn, influence its long-term development positively.

LuxUrban Hotels (LUXH), closed Wednesday's trading session at $1.67, off by 2.907%, on 7,844 volume. The average volume for the last 3 months is 43,419 and the stock's 52-week low/high is $1.24/$5.00.

Lucid Diagnostics (LUCD)

MarketBeat reported earlier on Lucid Diagnostics (LUCD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lucid Diagnostics Inc. (NASDAQ: LUCD) is a commercial-stage medical diagnostics technology firm that is focused on the development of products to diagnose and treat conditions of the esophagus, including conditions arising from chronic heartburn which may lead to esophageal cancer.

The firm has its headquarters in New York and was incorporated in 2018, on May 8th. It operates as part of the medical devices industry, under the healthcare sector. The firm serves consumers around the world. It operates as a subsidiary of PAVmed Inc.

The enterprise’s lead products include a laboratory developed esophageal DNA test dubbed EsoGuard, a bisulfite-converted next generation sequencing (NGS) deoxyribonucleic acid (DNA) assay performed on surface esophageal cells collected with EsoCheck. It also develops an esophageal cell collection device dubbed EsoCheck, which is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in an office procedure. It comprises of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. This is in addition to developing EsoCure, which is an esophageal ablation device to treat dysplastic barretts esophagus (BE) before it can progress to EAC.

The company recently gave an update on its operations, with its CEO noting that they were focused on accelerating the commercialization of its products. This will not only help the company execute on its strategic objectives and generate additional revenues for the company but also generate value for its shareholders.

Lucid Diagnostics (LUCD), closed Wednesday's trading session at $1.3, off by 0.763359%, on 43,420 volume. The average volume for the last 3 months is 58,629 and the stock's 52-week low/high is $1.105/$4.0598.

ZyVersa Therapeutics (ZVSA)

The Stock Dork, QualityStocks, FreeRealTime and 247 Market News reported earlier on ZyVersa Therapeutics (ZVSA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ZyVersa Therapeutics Inc. (NASDAQ: ZVSA) is a clinical-stage biopharmaceutical firm that is focused on the development and commercialization of products to help treat inflammatory and renal illnesses.

The firm has its headquarters in Weston, Florida and was incorporated in 2014 by Stephen C. Glover. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company’s mission is to develop novel, first-in-class drugs that optimize health outcomes and improve patients' quality of life. Its evolving product pipeline is targeted at renal and inflammatory diseases with high unmet medical needs.

The enterprise’s product pipeline is comprised of a renal drug candidate named VAR 200 (2-hydroxypropyl-beta-cyclodextrin or 2HPβCD), a cholesterol efflux mediator for the treatment of rare kidney disease and focal segmental glomerulosclerosis. This formulation has potential to treat other glomerular diseases, including alport syndrome and diabetic kidney disease. It mediates the removal of excess intracellular lipids that contribute to kidney damage leading to end-stage renal disease. The enterprise also develops a drug candidate dubbed IC 100, an inflammasome ASC inhibitor for the treatment of a multitude of inflammatory ailments.

The firm, which recently appointed a new Chief Medical Officer, remains committed to developing therapies for inflammatory and renal illnesses with unmet medical needs. The success and approval of its formulations will not only benefit patients afflicted with these conditions and help improve their quality of life but also encourage more investments into the firm.

ZyVersa Therapeutics (ZVSA), closed Wednesday's trading session at $1.7604, off by 4.3261%, on 59,555 volume. The average volume for the last 3 months is 235,057 and the stock's 52-week low/high is $1.38/$25.00.

Compass Pathways PLC. (CMPS)

QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, StreetInsider, Schaeffer's, Trades Of The Day and The Street reported earlier on Compass Pathways PLC. (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dozens of states have launched medical and recreational cannabis industries over the past two decades amid a wave of drug reform that has swept across the country. In the past couple of years, reformists in several states have also begun campaigns to legalize, or at least decriminalize, psychedelic drugs as initial research has shown that those drugs have potential as mental health treatments.

However, while states are increasingly adopting permissive drug policies, federal law still bans the production, distribution and use of drugs such as cannabis and psychedelics even though millions of people across the country now use them either recreationally or therapeutically.

This mismatch between state and federal law has been a bone of contention for reform activists, lawmakers and players in these emerging industries. The situation has created numerous challenges to both businesses and consumers who use or would like to use cannabis and psychedelics.

Congressional researchers recently called attention to the growing rift between state and federal-level drug laws as more states begin pursuing psychedelic drug reform. Released last week, the Congressional Research Service report focused on the federal Controlled Substances Act, which currently outlaws drugs such as psychedelics and cannabis, classifying them in the same class as heroin and cocaine.

The report noted that while Congress had always had the authority to challenge these federal drug laws, it had declined to do so on multiple occasions. As a result, the report noted, the already wide gap between federal and state law had continued to expand as more states chose to loosen their own drug policies.

With states such as Oregon and Colorado moving to legalize the use of certain psychedelics for adults for mostly medical reasons, this gap is widening even further. On top of that, lawmakers in Connecticut, Massachusetts and Oklahoma are also pursuing psychedelic reform in 2023. 

The Congressional report also stated that while the gap between federal and state cannabis regulation was well-known, other Schedules I controlled substances such as psilocybin seemed to be developing a similar gap in regulation. Even as more states look to legalize or decriminalize psychedelic drugs, any change they make to their respective drug policies will have no effect on the federal Controlled Substances Act, which currently outlaws psychedelic drugs.

According to the report, this disconnect between drug laws at the federal and state level has led to “collateral consequences” for people who take part in state-legal cannabis markets, such as difficulties accessing financial aid, federal benefits, assisted housing, firearms and employment.

This drive to reform psychedelic drug policy is in part being driven by the research being undertaken by startups such as Compass Pathways PLC. (NASDAQ: CMPS) leading to the demonstration of many therapeutic possibilities involving these substances.

Compass Pathways PLC. (CMPS), closed Wednesday's trading session at $10.61, up 2.2158%, on 235,327 volume. The average volume for the last 3 months is 3.12M and the stock's 52-week low/high is $6.54/$21.50.

Peabody Energy Corporation (BTU)

The Online Investor, The Street, MarketClub Analysis, StreetInsider, Schaeffer's, InvestorPlace, Daily Wealth, MarketBeat, SmarTrend Newsletters, The Growth Stock Wire, QualityStocks, Money Morning, Hit and Run Candle Sticks, Daily Markets, Barchart, TheStockAdvisors, StreetAuthority Daily, TheStockAdvisor, TopStockAnalysts, TradersPro, Energy and Capital, Daily Trade Alert, BUYINS.NET,, Wealth Daily, Kiplinger Today, SmallCap Network, SureMoney, Zacks, WStreet Market Commentary, Street Insider, Wall Street Daily, ProfitableTrading, Forbes, Trading Concepts, The Motley Fool, Investment House, Investing Futures, The Wealth Report, Trades Of The Day, Market Report, Dividend Opportunities, Uncommon Wisdom, Dynamic Wealth Report, Investment U, Investors Alley, Wyatt Investment Research, TradingMarkets, StrategicTechInvestor, Trade of the Week, The Tycoon Report, Money and Markets, Top Pros' Top Picks, Stock Tips Network, FNNO Newsletters, Stockhouse, StockMarketWatch, StockTwits, Stock Gumshoe, Daily Stocks, Inside Investing Daily, Wealthpire Inc., Cabot Wealth, The Trading Report, Wall Street Elite, Trading Markets, Stock Beast, Investing Daily, AllPennyStocks, TheTradingReport, Today's Financial News, InvestmentHouse, Investopedia, InvestorGuide, SmallCapNetwork, Market Authority, Market Intelligence Center, Market Intelligence Center Alert, Top Stock Picks and INO Market Report reported earlier on Peabody Energy Corporation (BTU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

National Grid instructed coal-fired power plants to stand down hours after issuing them an order to “warm up” last week. The United Kingdom grid operator had asked one unit at West Burton, Nottinghamshire, and two in Drax, Yorkshire, to do so before midnight on Wednesday night.

The Electricity Supply Operator (ESO) asked the West Burton unit to stand down on Thursday morning before informing the two coal units in Drax later that they also would not be firing up. These three coal-fired power plants were placed on standby to produce additional power amid an energy crunch that has significantly increased fears of blackouts during winter.

National Grid has been working to balance power supplies in the country over the past couple of weeks as cold and less windy weather has increased energy use in households while simultaneously reducing power generation from wind turbine stations.

In January, the energy company began running a demand flexibility program that allows it to pay some households with smart meters to reduce their energy use at peak demand times. This allows the ESO to reduce power generation from polluting sources such as coal at peak energy consumption times; the program also includes some businesses. National Grid is expected to pay suppliers and households slightly more than $3,714,300 as part of its energy-saving service.

The energy-saving scheme was debuted by Octopus Energy in 2020 and expanded to other suppliers in November. More than a million households and businesses signed up for the energy-saving program when it was officially launched last week. The program will most likely expand over time and include home batteries and electric vehicles.

However, according to National Grid, the latest instruction to warm up wasn’t because of sudden cold weather that increased demand while reducing power supply. The ESO said that it was due to a request for assistance from French power grid operator RTE, which feared a critical disruption in electricity generation due to strike action on Thursday.

The French grid operator later determined that the additional power from the coal-fired facilities wasn’t needed, resulting in the stand-down order. France and Britain are linked by subsea interconnector cables that allow grid operators to move electricity from one country to another based on demand.

According to the ESO, the coal-fired power plants would only have been able to provide power to send to France if it was determined that those resources were not essential in the prevention of energy shortages in Great Britain.

These coal plants show just how vital the commodity produced by companies such as Peabody Energy Corporation (NYSE: BTU) still is in providing an energy source countries can rely on, at least for the foreseeable future.

Peabody Energy Corporation (BTU), closed Wednesday's trading session at $27.68, off by 0.752958%, on 3,758,215 volume. The average volume for the last 3 months is 657,752 and the stock's 52-week low/high is $10.59/$33.29.

Bit Mining Ltd. (BTCM)

QualityStocks, MarketClub Analysis, Schaeffer's, Wall St. Warrior, StocksEarning, smartmoneytrading, MarketBeat, INO Market Report and 247 Market News reported earlier on Bit Mining Ltd. (BTCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin has had a great run with a near 40% rise this year, even after Genesis, a crypto lender declared bankruptcy months after FTX sunk in November. Let us decipher the driving force behind the cryptocurrency rally.

Most markets have their peak sales in January as money is deployed then by fund managers, according to industry insiders. This year has seen a rise in risk assets as NASDAQ registered an 8.8% gain. Bitcoin on the other hand was massively shorted after FTX caved in last year. This January during crypto’s unexpected price rise, short sellers closed their positions to buy Bitcoin, skyrocketing the price further.

Following the FTX’s closure, open contracts for Bitcoin on Deribit climaxed, indicating optimum activity levels, noted Luuk Stijers, chief commercial officer at Deribit. Crypto market panic may have eased in January with market indicators suggesting an institutional interest resurgence.

Despite the Bitcoin comeback, experts envision further drawbacks, which may cause a drop below the $15,480 previous fall. Analysts think the market has more risks than opportunities currently.

There is a challenge macroeconomically, owing to high inflation rates and looming recession in the United States. Following the collapse of several crypto enterprises, regulators can drown the market to new lows quite easily, observers say. But Stijers is hopeful that the rally will push the market into recovery mode.

Tesla did not trade in Bitcoins during 2022’s final months, even though Bitcoin fell to $15,480, the lowest in two years. Tesla banked on Bitcoin and invested $1.5 billion in 2021 when crypto was trading at more than $30,000. Tesla noted a $34 million loss in the last quarter, indicating digital asset value at $184 million, a fall from $218 in September.

The Bitcoin prices rose in the past week, trading at $23,027, while Ether gained 5% ($1,610) in the same period, noted CoinDesk data.

Here are how some crypto companies traded in the past week:

Coinbase Global Inc. amassed 8.6% to get $53.67 last week while MTSR shot up 9.6% to $242.77. Riot Blockchain rose 7.1%, and rival company, Marathon Digital Inc., went up 17.9% gaining $8.65. EBON stocks lost 10.9% in the past week.

ProShares BITO rose to 9.3% while Short Bitcoin ETF BITI dropped to $27.53. Grayscale Bitcoin GBTC went up 5.5% to reach $12.13 by Thursday last week.

It would be interesting to track how other crypto mining companies such as Bit Mining Ltd. (NYSE: BTCM) fared in comparison to the other industry actors on a week-by-week basis.

Bit Mining Ltd. (BTCM), closed Wednesday's trading session at $3.88, up 13.1195%, on 696,269 volume. The average volume for the last 3 months is 22,069 and the stock's 52-week low/high is $1.40/$34.799.

The QualityStocks Company Corner

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Arizona Metals owns two highly compelling properties in Arizona,the Kay Mine Project and Sugarloaf Peak

The company had $58 million in cash at the end of Q3, enough tocomplete its ongoing Phase 2 drilling program, as well as a largePhase 3 program to continue building the resource at the Kay MineDeposit, and explore around it for additional deposits

The latest drill results provided more compelling data, includingdiscovery of a new gold/copper zone and extension of knownmineralization

The U.S. mining industry produced $90.4 billion in non-fuel metals in 2021, with Arizona being the single-largestproducer on a percentage bases, outshining neighbor Nevada as theonly two states to command double-digit share at 11.0% and 10.3%,respectively. Arizona is widely known for its copper and goldprowess, contributing a whopping 71% of the nation’s copperproduction in 2021. If Arizona Metals (TSX: AMC) (OTCQX: AZMCF) has anything to say about it, the state will continue itsdominance for decades to come as it unearths a world-classgold/copper/zinc VMS (volcanogenic massive sulfide) deposit.

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.


Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Vision Energy Corp. (OTCQX: AZMCF), closed Wednesday's trading session at $3.14, up 0.319489%, on 22,069 volume. The average volume for the last 3 months is 1,200 and the stock's 52-week low/high is $2.30/$5.60.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform,is featured in an editorial published by NetworkNewsWire ("NNW").The editorial discusses the booming market for renewable energy;much of the growth is rooted in growing concerns about climatechange, energy security and global initiatives to reign in carbonemissions. To add to the momentum, the Inflation Reduction Act(IRA) was signed into law last last year. The act is the largestinvestment to date made by the U.S. government in renewableenergies and budgets $369 billion to accelerate efforts to reducedependence on fossil fuels. NNW is one of more than 50 trustedbrands within the InvestorBrandNetwork (“IBN”), a multifacetedfinancial news and publishing company for private and publicentities.

“According to some experts, the IRA is expected to more than tripleAmerica’s clean-energy production by 2030, resulting in about 40%of the nation’s energy coming from sources such as wind, solar andrenewable natural gas (RNG),” the editorial states. “For this tohappen, about 550 gigawatts of new energy supply from green sourceswill come online over the next seven years. Against the backdrop ofthis generational opportunity, EverGen Infrastructure Corp. (TSX.V:EVGN) (OTCQX: EVGIF), a specialist in RNG, has positioned itself asan emerging leader in the booming renewables sector.”

To view the full editorial, visit

To view the full press release, visit

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Wednesday's trading session at $2.17, up 10.7143%, on 1,200 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.60/$.

Recent News

Cybin Inc. (NEO: CYBN) (OTC: CYBN)

The QualityStocks Daily Newsletter would like to spotlight Cybin Inc. (NEO: CYBN) (NYSE American: CYBN).

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelicsto Therapeutics(TM), has received key approval to initiate humandosing of CYB004, its proprietary deuterated N,N-dimethyltryptamine(“DMT”) molecule, through a protocol amendment to its ongoingCYB004-E phase 1 trial. The approval came from an independentethics committee in the Netherlands. The first-ever trial thatevaluates deuterated DMT in humans, the study is being conducted atthe Centre for Human Drug Research in the Netherlands; it is thelargest-ever Phase 1 DMT trial conducted to date. Based on previousstudies, CYB004 has shown potential to deliver an improvedbioavailability and pharmacokinetic profile in comparison to DMTwhen administered via intravenous and inhaled routes, as well asdeliver a longer duration of effect and offer more convenientdosing methods through inhaled, subcutaneous or intramuscularroutes of administration. “This is a major milestone for our CYB004program and for better understanding the potential therapeuticbenefits of our proprietary deuterated DMT molecule for thetreatment of generalized anxiety disorder,” said Cybin CEO DougDrysdale in the press release. “The ability to evaluate our novelCYB004 molecule in humans at this early stage is a significantachievement in clinical development and will provide importantinsight into the pharmacokinetic and pharmacodynamic properties ofCYB004 in addition to what we have already learned through ourstudy of DMT. We expect to apply these findings to optimize dosingand delivery of CYB004 in future clinical trials, which supportsour mission to bring this new investigational therapy to patientsas quickly as possible.”

To view the full press release, visit

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin ( Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), closed Wednesday's trading session at $0.4359, up 12.3454%, on 3,967,751 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2649/$1.16.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Auto manufacturers are experimenting with various strategies toenlist dealers in their conversion to electric vehicles as theypursue the kind of profits Tesla is making on electric vehicles. Several companies, including Honda, areshifting to more automobile sales online. The relationship betweenautomakers and franchised dealers is supported by rules in mostcountries that make it hard for automakers to sell their newvehicles to customers directly without going through franchiseddealers. Tesla and other recent autocar companies have found ways to avoid these restrictions and save money. Car producers arereconsidering the sales procedures, which include selling new carspartly or entirely online. As more companies roll out electricvehicles, despite maintaining physical dealers and informativewebsites as well as service outlets, Tesla was one of the firstvehicle companies to adopt internet sales for a sizable portion ofits business. As the industry evolves, there is no doubt that someconsensus will be reached by car manufacturers such as Mullen Automotive Inc. (NASDAQ: MULN) regarding the role that dealerships play as electrification growsto dominate the transport industry.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $0.3513, up 2.1518%, on 150,963,418 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.18/$4.1799.

Recent News

MetAlert Inc. (OTC: MLRT)

The QualityStocks Daily Newsletter would like to spotlight MetAlert Inc. (OTC: MLRT).

MetAlert (OTC: MLRT) is a pioneer in location-sensitive health devices and wearabletechnology products for remote patient monitoring. The company“has, since inception, sought to offer quality-of-life improvementsto patients and consumers who have Alzheimer’s, dementia and autism(‘ADA’)… Its flagship GPS SmartSoles HUB launched in the fourthquarter of the 2022 financial year, allowing for remote monitoring,data collection and encrypted data transmission to the cloud. Inaddition, RoomMate, MetAlert’s latest offering, allows caregiversto monitor patient behavior that could lead to falls and injurieswithout invading their privacy. As evidenced by these two products,MetAlert prioritizes patient confidentiality while pushing theneedle regarding the use of technology to improve service deliveryand the quality of life of patients afflicted with ADA,” a recentarticle explains. “The focus on this target population has alsoseen MetAlert offer hearing aids, ranging from its flagship Hear IQ4 rechargeable, app-controlled hearing aid to the NRBznoise-reducing buds. The company also offers HearingVite, aformulation proven to boost memory and cognitive function amongindividuals aged 50 years and above. It also offers Ear-RingRelief, a formula that integrates vitamins, minerals andnutritional supplements to relieve tinnitus sufferers.” To view thefull article, visit

Heart disease is one of the most prolific killers in America,taking one life every 34 seconds and affecting nearly one-half of the country’s population. According to a new study from the University of California, SanFrancisco, people who develop heart disease earlier in their liveshave an increased risk of experiencing cognitive decline later inlife. The study found that people who suffer strokes or heart attacks in middle age mayhave problems with thinking and memory when they grow older. Morespecifically, the study focused on individuals who developed heartdisease or leg artery disease, or who suffered a stroked beforethey turned age 60.Dr. Xiang Jiang, who led the study, and her team analyzed health data from more than3,100 Americans that was collected for up to 30 years from youngadulthood. The study showed that 5% of those in the study developedcardiovascular disease, usually stroke and heart disease, in middleage; these same individuals performed poorly in cognitive tests they took in their 50s. Cognitive decline can have devastatingeffects on not just the patients but also their families andcaregivers. Health monitoring devices commercialized by companiessuch as MetAlert Inc. (OTC: MLRT) go a long way toward making it easier to take care of someonesuffering from dementia and other forms of cognitive decline.

MetAlert Inc. (OTC: MLRT) is a pioneer in location sensitive health monitoring devices (estimated $47 billion industry in 2021) and wearable technology products (industry forecast to reach $174 billion by 2030).

With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leader for consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA). This market represents approximately 2.9% of the world’s population (approximately 34 million people in 24 developed countries). Due to specific behaviors (problems with memory, adversity to wearing unknown items, etc.) of consumers/patients in this market segment, traditional products, such as an iPhone or Fitbit, are not a practical solution. This has created a significant market with very few competitors for MetAlert.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, and selling products and services in GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The company offers a global end-to-end hardware, software, and connectivity solution, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products and enterprise applications.

Using its award-winning, patented GPS SmartSole® as a hub for collecting and transmitting data to the cloud in real-time, MetAlert is expanding its value proposition to consumers and increasing its revenue per user (RPU) while creating the largest database of health statistics for ADA consumers/patients. MetAlert generates revenue from product sales, recurring subscriptions, intellectual property (IP) licensing, and professional services. The company has international distributors servicing customers in over 35 countries and is an approved U.S. military government contractor. Its customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers.

The company is headquartered in Los Angeles, California, with a sales office in London, England, and distributors across the globe.


  • GPS SmartSoles® HUB (launched Q4 2022) is a GPS/BLE-equipped insole that allows remote monitoring, data collection, and encrypted data transmission to the cloud.
    • Telehealth (available Q4 2022) allows access remotely to doctors and other health professionals on an as-needed basis. This service will also function as the prescribing doctor once Medicare reimbursement codes are established.
    • Concierge (available Q4 2022) provides 24/7/365 enhanced emergency response that coordinates with all relevant parties to quickly detect false alarms and escalate response as needed.
    • Bluetooth Enabled Devices (available Q1 2023) include third-party devices that collect vitals and other health data and connect with the GPS Smartsoles® HUB.
    • Artificial Intelligence (available Q1 2023) software will evaluate the Teradata of health information identifying trends and respond to preestablished alert thresholds.
  • Take-Along Tracker is a small GPS tracking device – less than three inches long – that works with 4G cellular service and will have the same “HUB” functionality as the GPS Smartsoles®. This versatile and affordable mini tracker boasts super long battery life, with up to 14 days of operation per charge.
  • RoomMate™ is a wall-mounted alert system that detects and alerts caregivers about patient behavior that could lead to falls and injuries. The system features 3D infrared and wall-mounted sensors, eliminating the need for any other physical installation or wearables. RoomMate™ offers patient privacy by design. Images are not stored, but all actions are logged. It’s a unique solution for looking after patients without intruding on their personal space.

Market Outlook

According to Grand View Research (Patient Monitoring Devices Market Size & Share Report, 2030), the global patient monitoring devices market size was valued at $47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The growing number of chronic disorders, such as diabetes, stroke, and kidney disease, are driving the demand for patient monitoring devices. For instance, according to the World Health Organization (WHO), about 422 million people globally have diabetes. Likewise, the number of asthma and chronic obstructive pulmonary disease patients (COPD) is increasing rapidly.

According to the WHO, around 235 million people suffer from asthma. As a result, peak flow meters, which are used to gauge respiration rate, are increasingly used. The market for patient monitoring devices is driven by the simplicity with which it is handled, transported, and remotely accessible. Major market players are engaging in a variety of tactics to expand the industry, including partnerships, cooperation, innovation, launches, and mergers.

During the COVID-19 outbreak, social segregation and quarantining procedures were put into place worldwide. Many people avoided regular hospital visits as a result. Many people now need routine home temperature and oxygen level monitoring to maintain track of their health, thereby demanding monitoring devices at home.

Various government programs are supporting the pandemic outbreak. The FDA has granted Emergency Use Authorizations (EUAs) for a few wearables and patient monitoring devices to improve access to medicines, monitor patients more closely, and lessen the risk of SARS-CoV-2 exposure to medical professionals during the COVID-19 pandemic.

The growing popularity of wearable and remote patient monitoring devices is another factor fueling the market’s expansion. By fusing clinical symptomology with vital indicators, wearable technology helps in the diagnosis of many chronic diseases. Thus, there has been a dramatic rise in the usage of wearable technology to combat COVID-19.

The wearable medical device market is anticipated to reach $174.48 Billion by 2030, expanding at a 27.1% CAGR during the forecast period (2022-2030), according to Market Research Future.

MetAlert identifies the total addressable market for its wearable patient monitoring tech for those with Alzheimer’s, dementia, and autism at more than 34 million potential patients in North America, Europe, South Africa, and Asia.

Management Team

Patrick E. Bertagna is Founder, CEO and Chairman at MetAlert. He began his career in apparel sales in 1983 and was promoted to national sales manager within two years. In 1986, he founded his first company importing apparel from Europe and selling to U.S. retailers from JCPenney to Neiman Marcus. He has founded several technology and apparel companies, including MetAlert in 2002, which he took public in 2008. He attended Cal State University Northridge with a business major and a psychology minor.

Louis Rosenbaum is COO of MetAlert. He co-founded Global Trek Xploration and was an initial investor in MetAlert. He has successfully started companies in multiple industries, including apparel, environmental services, and the music industry, achieving annual revenues in the multi-millions of dollars. He previously was president of Elements, a women’s apparel company, and of Advanced Environmental Services.

Alex McKean is CFO at MetAlert. He is also the CFO of Encore Brands Inc., a position he has held since 2009. He has held positions as Controller and VP of Finance at 24:7 Film and, Director of FP&A/SVP at Franchise Mortgage Acceptance Company, Corporate Accounting Manager/Treasurer of Polygram Filmed Entertainment and Assistant Treasurer/Controller for State Street Bank. He holds an International MBA from Thunderbird School of Global Management and undergraduate degrees in business and political science from Trinity University.

MetAlert Inc. (OTC: MLRT), closed Wednesday's trading session at $0.1751, up 12.9677%, on 7,691 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.06/$1.00.

Recent News

SideChannel Inc. (OTCQB: SDCH)

The QualityStocks Daily Newsletter would like to spotlight SideChannel Inc. (OTCQB: SDCH).

SideChannel (OTCQB: SDCH), a leading cybersecurity firm with a growing list of formerenterprise level chief information security officers (“CISO”)delivering vCISO services to clients, was featured in the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution viawidespread syndication channels. Brian Haugli, the company’s CEO,joined the latest episode to share insight into his background in the cybersecurity industryand discuss the company’s business model and operating markets.“SideChannel’s job is to make cybersecurity simple and accessible.We are a cybersecurity firm with products and services, and webring a wealth of experience from our collective backgrounds. Ihave been a cybersecurity expert in the industry for a little over20 years, within the Department of Defense and corporate America,along with my entire executive team,” Haugli said. “We’ve seen areal and obvious need to address cybersecurity at an operationallevel – from the top of the company – versus what it’straditionally been, which is an IT issue. Our focus is to bringreal cybersecurity expertise, solid products and tech-enabledservices into the types of companies that can’t usually afford theright types of full-time resources. We’re predominately focusing onthe middle market and startups.”

To view the full press release, visit

SideChannel Inc. (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time CISO.

SideChannel’s team of virtual Chief Information Security Officers (vCISOs) possesses a combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise.

SideChannel is committed to creating top-tier cybersecurity programs for SMBs to help them protect their data and assets. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients.


Reports show that cyberattacks on SMBs have increased in recent years, as organizations’ network attack surfaces have grown exponentially with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications and third-party suppliers to conduct business.

SideChannel continues expanding its service offerings, workforce and customer base, attracting over 20 virtual CISOs to serve across industries including fintech, biotech, healthcare, manufacturing, legal, defense and technology services. The company is based in Worcester, Massachusetts.

Market Opportunity

An analysis from ReportLinker states that the global cybersecurity market is expected to grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving cyber security market growth, according to the report.

A lack of cybersecurity professionals and the budget constraints among SMBs and start-ups in developing economies are expected to hinder market growth. Cybercriminals are using automated techniques to attack SMBs’ networks to take advantage of their weak security infrastructures. To save money, time and resources, SMBs are seeking cybersecurity solutions.


Enclave expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool.

A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency and strengthen overall security defense.

Enclave creates the foundation for a Zero Trust network security model IT can build upon.

With Enclave, IT can easily segment their company’s network, organize personnel and computing devices at the employee workload level, and implement security controls across all network segments.

Enclave was designed and purpose built to serve the growing security needs of SMBs, a traditionally underserved market that is more prone to cyberattacks but has limited protection due to smaller budgets, inadequate IT security staffing and a lack of cybersecurity awareness among top executives.

Enclave is an affordable and effective network security solution that shrinks the attack surface area exposed to a cyber intruder and significantly reduces the amount of effort required to operate securely.

Management Team

Brian Haugli is CEO of SideChannel. He has led programs for the U.S. Department of Defense, the Pentagon, and Fortune 500 companies. He is an expert on National Institute of Standards and Technology guidance, threat intelligence implementations and strategic organizational initiatives. He is a professor at Boston College, Woods College of Advancing Studies Master’s Program in Cybersecurity. He is also a contributing author for the Wiley book ‘Cybersecurity Risk Management’.

Ryan Polk is CFO at SideChannel. He has been the principal of Perissos Partners, an executive consulting firm, since June 2017. He also served in executive roles in the portfolio companies owned by Lacy Diversified, with combined revenue approaching $2 billion. He served as the Vice President for Corporate Financial Planning and Analysis for Brightpoint, a publicly traded, Fortune 500 mobile device logistics company. He earned a bachelor’s degree in accounting and industrial management from Purdue University.

Nicholas Hnatiw is Chief Technology Officer at SideChannel. Prior to joining the company, he served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence Agencies and other Department of Defense research organizations. He was also the CEO of Loki Labs, a cyber security firm. He earned a bachelor’s degree in computer engineering and computer science at the University of Massachusetts, Amherst.

Bill Roberts is SideChannel’s CISO. He most recently served as the vice president, IS & CISO for Hologic Inc., a global medical device company, where he established cyber security and IT compliance programs. Prior to Hologic, he was vice president of information security for Cytyc Corporation, which was acquired by Hologic in 2007. At Cytyc, he managed global IT as the company grew from 140 employees to 1,500 and from $40 million in revenue to over $750 million.

SideChannel Inc. (OTCQB: SDCH), closed Wednesday's trading session at $0.1032, up 7.0539%, on 5,002 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0675/$0.18.

Recent News

REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

REZYFi, a growth mortgage origination and specialized financing companythat targets licensed and permitted cannabis companies, owners ofreal estate who lease to cannabis companies and companies andindividual homeowners, is set to benefit from the growing supportfor the cannabis industry. “The United States Department ofAgriculture (‘USDA’) is set to include hemp data in its 2022 Censusof Agriculture. It is noted that with this inclusion, theorganization is pushing the conversation around hemp and marijuanaforward. It also signals the eventual integration and support ofthe overall cannabis industry. With this support, various companieswithin the sector are set to benefit, REZYFi being one of them,” arecent article reads. “REZYFi is banking on the federallegalization of this product. Its management is optimistic thatthis recent move by the USDA to include hemp data is a step in theright direction. More importantly, the company understands thatthis inclusion gives farmers a voice in the matter and the power toinfluence policy in a way that would favor the industry’s growth…The increasing support of the cannabis industry is proving morepromising while presenting many growth opportunities for companiessuch as REZYFi.” To view the full article, visit

Currently, cannabis is legal in 21 states for recreational usageand 39 states for medical use, with total revenues anticipated toexceed $38.8 billion through 2023. The next logical stage in the development of the cannabis market is federal financial regulation for complying enterprises.Theoretically, most other sectors’ opportunities for credit cards,deposits and loans should be available to the marijuana business aswell. However, there hasn’t been a legislative majority or thepolitical desire to make tax and banking reform regarding cannabisbusiness to happen, despite numerous efforts in Congress to do so.Despite numerous attempts, the usual bills from opposing parties inthe U.S. Congress and Senate — MORE, CAOA and SAFE — have not been successfully passed. Furthermore, the outcomes of the latest elections do not indicate any quick progress. Therefore, national financialreform may eventually lead to a lower cost of borrowing, but youshouldn’t count on it in the short-term. Entities such as REZYFi Inc. are working to bridge the financing gap for marijuana industryplayers. More actors of this nature could eventually help theindustry thrive despite lacking access to mainstream banks.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

It is not only the environment that is threatened by greenhouse gas(“GHG”) emissions but human health; some sources of carbonemissions released from staple home appliances such as gas stovesalso produce toxic pollutants that can exacerbate asthma, a recentstudy shows

While electrification can slash GHG, it also increases pressure onthe aging grid and blackouts are growing in frequency; for manyhomeowners, an answer can be to get off the grid

GeoSolar’s SmartGreen(TM) Home system uses natural energy sourcesfrom the sun and ground to electrify homes without any fossilfuels; offers solutions that can improve indoor air quality andhealth of residents while increasing energy independence andreducing home’s carbon footprint

GeoSolar Technologies (“GST”) looks at another promising opportunity as more and moreevidence surface about the harmful effects of GHG emissions notonly on the environment but on human health as mounting evidenceemerges that gas stove pollution can cause health problems such asasthma ( The company’s SmartGreen(TM) technology combines solar,geothermal, and other green systems in an innovative package thatimproves indoor air quality and the health of the residents whilereducing or eliminating carbon emissions. Moreover, thispatent-pending system helps homeowners increase energy independencewhile slashing–or even eliminating–utility bills that millions ofAmericans have seen soaring as of late.

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) executive VP of exploration Bill Pearson was a spotlighted guestduring the latest The Power Play by The Market Herald interview.During the segment, Peterson and host Sabrina Cuthbert discussedthe latest news from Eloro Resources concerning assay results fromadditional diamond drill holes from the Iska Iska silver-tinpolymetallic project in southern Bolivia. Eloro is an explorationand mine development company with a portfolio of gold andbase-metal properties in Bolivia, Peru and Quebec. The Power Playby The Market Herald interviews with company executives aredesigned to offer investors with a glimpse of what key informationabout the company's latest press release. The Market Herald Canadais a leading source of stock market news for self-directedinvestors. The Market Herald reporters, editors and technologistscovers news for some 3,985 businesses.

To view the full interview, visit

To view the full press release, visit

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Wednesday's trading session at $2.5, off by 1.9608%, on 145,706 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.09/$4.46.

Recent News

Jupiter Wellness Inc. (NASDAQ: JUPW)

The QualityStocks Daily Newsletter would like to spotlight Jupiter Wellness Inc. (NASDAQ: JUPW).

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, todayannounced that Dr. Hector Alila has rejoined its board of directorswith the specific responsibility of building a technical advisoryboard. “We are pleased to welcome Hector back to our board. Withour focus on new scientific and clinical programs, our immediateneed is to build a top-tier team of technical advisors to reviewour R&D activities and scientific approaches,” said Dr. GlynnWilson, board chairman. “Dr. Alila brings 30 years of experience intranslating novel research into clinical programs and productopportunities. He was most recently at Esperance Pharmaceuticalswhere he guided the clinical development of novel targeted cancertherapeutics. With a Ph.D. in physiology and immunology, and abroad R&D background covering cancer, autoimmune disease,infectious diseases, and gene therapy, he will be pivotal inhelping us establish an advisory group and moving Jupiter Wellnessforward into clinical trials and working with the FDA.”

To view the full press release, visit

Jupiter Wellness Inc. (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary products.

Jupiter Wellness’s product pipeline, backed by clinical research to ensure efficacy, addresses a range of underserved conditions. The company’s revenue is generated through a combination of OTC and consumer product sales, contract research agreements, and licensing royalties.

Jupiter Wellness was formed in 2018 and is headquartered in Jupiter, Florida.

Products with Purpose

Jupiter Wellness’s product pipeline currently targets a variety of indications with underserved needs. These include:

  • Hair Loss – Jupiter Wellness’s Minoxidil Booster is a topical treatment that’s been clinically shown to increase the enzymes needed for minoxidil to work by up to 7x over a two-week period. The product has been licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, which expects to launch it commercially in 2023. The product is licensed to India-based Cosmofix Technovation Pvt. Ltd. and Sanpellegrino Cosmetics, and additional licensing opportunities are being pursued.
  • Psoriasis & VitiligoPhotocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. The product has been licensed abroad and is currently being launched commercially in India by Eris Oaknet Healthcare and Cosmofix Technovation under the brand name PhotoFirst. The product is also available in the U.S., and the company is working to find new partners in dermatology for expanded distribution.
  • Jellyfish Protection SunscreenNoStingz is a topical protection from jellyfish, sea lice, and UVA/UVB rays. It provides an effective barrier against the stinging mechanism of jellyfish cnidocytes, preventing the delivery of venom to the victim. NoStingz is currently available online through Amazon and Walmart, as well as in select stores.
  • EczemaJW-100 is a pre-revenue topical treatment for atopic dermatitis (eczema). In prior studies, JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. It is currently being evaluated in a Phase 3, double-blind, placebo-controlled multicenter trial.
  • BurnsJW-300 is a pre-revenue topical treatment for first-degree burns and sun exposure. In prior studies, JW-300 was shown to significantly lower the incidence of burns in patients exposed to UV radiation. It is currently being evaluated for sale as an “after sun” consumer product.
  • Cold SoresJW-400 is a pre-revenue topical treatment of herpes labialis (cold sores). A phase 1, double-blind, placebo-controlled investigational study is currently being planned for JW-400.
  • Sexual WellnessJW-500 is a pre-revenue topical treatment for female libido loss. In clinical studies, the topical formulation improved nipple sensitivity and alleviated associated sexual problems. Jupiter Wellness plans to file for a pre-IND meeting with the U.S. FDA within the next 12 months and intends to seek Orphan Drug Designation.
  • COVID-19-Induced TinnitusJW-600 is currently being evaluated in a triple-blind clinical study. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus

Management Team

Brian John is the CEO of Jupiter Wellness. For the past 20 years, he has been an investor and advisor to companies around the globe. He is the founder of a successful financial consulting firm specializing in helping emerging growth companies and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John also serves on the board of directors of The Learning Center at the Els Center of Excellence – a school for children with autism in Jupiter, Florida.

Doug McKinnon is the CFO of Jupiter Wellness. His 35+ year professional career includes financial, advisory, and operational experience across a broad spectrum of industry sectors, including oil and gas, technology, cannabis, and communications. He has served in C-Level positions in both private and public sectors, including as chairman and CEO of an American-stock-exchange-traded company; as VP – Chief Administrative Officer of a $12-billion-market-cap Nasdaq-traded company; as CFO of several publicly-held U.S., Canadian and Australian companies; and as CEO/CFO of various other private enterprises.

Dr. Glynn Wilson is the Chief Scientific Officer of Jupiter Wellness. He brings to the company an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals; Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals; and Founder, CEO, and Chairman of TapImmune Inc., which became Marker Therapeutics through a merger. At TapImmune, he licensed cancer vaccine technology platforms and established the clinical pipeline.

Jupiter Wellness Inc. (NASDAQ: JUPW), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

Earlier this week, the FDA published its final guidance on cannabisdrug development in the federal register. This comes after itreleased a draft version in 2020. The guidance outlines the basic clinical study standards, considerations for researchers and the drug development process.The legalization of hemp in the 2018 Farm Bill is one major reason for the guidance’s release because it made thedrug development process for hemp different from marijuana, whichis still classified as a Schedule I substance under the ControlledSubstances Act. In its statement, the agency said that theguidance outlined its views on topics related with the development of cannabis and cannabis-deriveddrugs for humans. The FDA also made a number of nonbindingrecommendations for scientists interested in the development ofcannabis drugs that could be commercialized. The advice, the agencynoted, was centered on addressing the regulatory controls and legaldefinitions related to cannabis as well as specific questionsraised about drugs that contained cannabis. For entities that arealready conducting cannabis drug development, such as India Globalization Capital Inc. (NYSE American: IGC), the new guidance may simply clarify what they are already doingbecause any clinical development program can only take place oncethe needed approvals are granted by regulators, such as the DEA andthe FDA.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Wednesday's trading session at $0.395, off by 1.25%, on 186,255 volume. The average volume for the last 3 months is 179,339 and the stock's 52-week low/high is $0.2785/$1.16.

Recent News

Data443 Risk Mitigation Inc. (OTC: ATDS)

The QualityStocks Daily Newsletter would like to spotlight Data443 Risk Mitigation Inc. (OTC: ATDS).

Data443 Risk Mitigation (OTC: ATDS) has emerged as a key player within the cyber security space,strategically positioned to benefit from increased demand for dataprotection with its portfolio of software solutions that allow fora unified approach to data governance and security. “In addition toits ransomware recovery and data protection services, Data443’sextensive product suite has provided the company with the abilityto deliver corporate solutions designed to securely manage data anddata privacy needs on-premises, in the cloud and in hybridenvironments… Data443’s multitude of offerings – anall-encompassing toolset including data archiving, file sharing,access control, sensitive content management and global privacymanagement, has seen the company pick up an impressive slate ofclients in recent months,” a recent article reads. “We continue toexpand the adoption of our product sets in some of the world’slargest organizations, supporting business-critical data in flightand at rest, in the cloud or on-premises. I am confident thatData443 is well positioned to make the most of the substantialmarket opportunity before us, continuing our mission: To organizethe world’s information by identifying and protecting all sensitivedata regardless of location, platform or format,” Jason Remillard,the company’s founder and CEO, is quoted as saying.

To view the full article, visit

Data443 Risk Mitigation Inc. (OTC: ATDS) is a data security and privacy software company for ALL THINGS DATA SECURITY™. The company is committed to organizing the world’s information by identifying and protecting all sensitive data regardless of location, platform or format.

Data443 provides software and services to enable secure data across devices and databases – at rest and in transit – locally, on a network, or in the cloud. With over 10,000 customers in more than 100 countries, Data443 provides a modern approach to data governance and security. The company’s framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies.

Data443 derives revenue primarily from contracts for subscriptions to access its SaaS platforms, and ancillary services provided in connection with its subscription services. In today’s ever-changing environment with unique and complex requirements for data privacy, governance and hybrid workforces, every organization needs to know where all their data is, who has access to it and how sensitive it is. Data443 provides the tools needed to give companies control over their data processing activities, with capabilities for identifying, reporting and migrating or deleting sensitive data.

The company is headquartered in Research Triangle Park, North Carolina.


Focused on data security with a privacy-forward methodology, the Data443 product suite delivers solutions designed to securely manage data and data privacy needs on-premises, in the cloud and in hybrid environments. Offerings include:

  • Data Identification Manager reduces risk by shining a light on dark data across cloud, on-premises and hybrid environments. From a centralized dashboard, Data Identification Manager provides the ability to automatically inventory all data repositories, classify and tag all data, and enable global search and discovery – all through an agentless deployment.
  • Data Placement Manager quickly and securely transfers sensitive data over any public or private network. Available as an HP Nonstop server-based application and for Windows, Linux or any public cloud provider, Data Placement Manager enables the scheduling, routing, formatting and transfer of business-critical data.
  • Data Archive Manager is an “all information, anywhere” archiving solution designed to handle and manage all types of privacy requests across cloud, on-premises and hybrid environments. With over 15 years operational history and hundreds of clients managing millions of mailboxes, the platform is purpose-built for information archiving, retention and privacy request management.
  • Data Hound™ is a data discovery, classification and capture toolset that enables organizations to perform quick scans, detailed reporting and subsequent data actions based on policy.
  • Ransomware Recovery Manager is the only industry solution that actively recovers the device, operating system and data with a simple reboot. Using patented, proven technology, the product produces 100% effectiveness for the whole device and datasets.
  • Access Control Manager provides user ID and passwordless access to quickly enable trust across an organization’s entire ecosystem. Its unique architecture allows it to leverage multiple distributed authoritative sources to understand and resolve a typical access request – with the ability to enable or deny the action on the fly.
  • Global Privacy Manager provides organizations one comprehensive view, for all privacy requirements, across all enterprise data, all at once. This unmatched visibility into an organization’s data assets ensures that all private and sensitive data can be identified and protected and that enterprises can obey all relevant privacy laws in any jurisdiction.
  • Sensitive Content Manager is a security-centric collaboration service designed to give organizations the tools needed for successful content sharing, collaboration and safe distribution with full enterprise management in mind. With a continuous sync feature, encrypted data is automatically downloaded and updated in real time – regardless of location – ensuring that users have the most accurate data available.

Market Outlook

A report from Allied Market Research estimates that the global data security market was worth about $19 billion in 2021 and is projected to reach a value of $54.23 billion by 2027. That represents a CAGR of more than 18% for the forecast period, making data security one of the hottest areas within IT.

Separately, Fortune Business Insights estimates the global data privacy software market is valued at $2.36 billion in 2022 and projects it will grow to $25.85 billion by 2029. That represents a CAGR of 40.8% over the forecast period.

Management Team

Jason Remillard is President, CEO and Founder of Data443. He is responsible for overseeing global expansion, management, execution and corporate development. With over 25 years in global enterprise and B2C software sales and marketing, he brings deep leadership and technical experience, having spent previous time at Fortune 500 companies such as Deutsche Bank, TD Bank, IBM & Merrill Lynch.

Greg McCraw is CFO at Data443. He has over 25 years of experience helping businesses strengthen their accounting and finance operations. He previously served as Vice President of Finance for a dental services organization active in acquisitions, and, prior to that, he was managing director of a boutique accounting and finance consulting firm advising Fortune 500 clients in pharmaceutical, financial services, and private equity sectors on how to execute on regulatory and compliance solutions.

Bennett Pursell is Data443’s Chief Technology Officer. He has over 20 years of experience in IT architecture, security governance and systems integration. Prior to his role at Data443, he served as Head of Technology Architecture at Moody’s Investor Services and was Vice President and Technical Architect of Cloud Computing at Deutsche Bank, along with a host of technical and project management roles dating back to 2006, after starting his career as a web developer with a few startups and running research labs.

Kirill Kashigin is Chief Software Architect at Data443. He leads the development and quality teams, and serves as technical adviser and subject matter expert, bringing vast technical knowledge on privacy management and data security. Formerly the CTO of FileFacets, he has nearly 20 years in development of high-performance systems and deployment.

Data443 Risk Mitigation Inc. (OTC: ATDS), closed Wednesday's trading session at $0.1678, off by 1.2941%, on 70,873 volume. The average volume for the last 3 months is 70,873 and the stock's 52-week low/high is $0.1557/$6.99.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.